Germany & United States — Food and Drug Administration
14 shared events · Importance 4 · Last updated Aug 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Germany: Germany is the home country of Boehringer Ingelheim, a key player in the antibody therapeutics market.
United States — Food and Drug Administration: The US FDA provides supportive regulatory frameworks that facilitate product approvals and market growth in North America.
Jul 28, 2026 · 6 articles
Regulatory
Germany: Germany is the home country of Carl Zeiss Meditec, with its headquarters in Jena. The event reflects positively on the German medical technology sector.
United States — Food and Drug Administration: The FDA granted 510(k) clearance for ZEISS CLINIC 360, a regulatory action that enables the product's commercial launch in the U.S. This clearance is a routine but essential step for medical device software.
Aug 19, 2026 · 6 articles
Business
Germany: Germany is one of the international markets where CannEpil has been made available.
United States — Food and Drug Administration: United States — Food and Drug Administration has engaged with the CannEpil program through the pre-IND process and assigned an Investigational New Drug (IND) number, laying the foundation for future U.S. clinical development.
Jul 06, 2026 · 6 articles
Accidents
Germany: Germany, along with other European governments, has also cut development aid, contributing to the overall reduction in global health funding.
United States — Food and Drug Administration: The United States — Food and Drug Administration has approved Inmazeb, a combination of antibodies, to treat Zaire Ebolavirus infection, which Regeneron Pharmaceuticals has donated for potential use in the current outbreak.
May 18, 2026 · 505 articles
Business
Germany: MiNK Therapeutics has commenced commercial launch of LYTENAVA (bevacizumab gamma) in Germany.
United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) granted MiNK Therapeutics' appeal, concluding that substantial evidence of effectiveness has been established for LYTENAVA, and will now review the resubmitted BLA with a decision expected within 60 days.
May 26, 2026 · 7 articles
Business
Germany: Germany is one of the countries where MiNK Therapeutics has commenced commercial launch of LYTENAVA. The offering does not directly affect Germany.
United States — Food and Drug Administration: The FDA approved LYTENAVA for the treatment of wet AMD. The offering does not directly affect the FDA.
Aug 12, 2026 · 7 articles
Tech
Germany: Germany is the country associated with Frank M. Bengel, an expert presenting at the Satellite Symposium.
United States — Food and Drug Administration: The United States — Food and Drug Administration has granted 510(k) clearance for several of United Imaging's uMI Panvivo PET/CT platforms, indicating regulatory approval for market use.
May 31, 2026 · 6 articles
Business
Germany: Germany is the location of AEG ID's headquarters, making it a base for the acquired company's operations.
United States — Food and Drug Administration: The United States — Food and Drug Administration encourages New Approach Methodologies, which are supported by Unified Information Devices' technologies for humane research practices.
Jun 12, 2026 · 7 articles
Business
Germany: Germany is a market where PEDMARQSI is commercially available.
United States — Food and Drug Administration: The United States — Food and Drug Administration approved PEDMARK, a key product of Fennec Pharmaceuticals, which provides background on the company's operational success.
May 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Germany and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard